Intimation of Earnings Presentation for Quarter 3 / 9 Months - Financial Year 2022-2023 [Q3/9M - FY23] Further to our intimation dated February 10, 2023 regarding approval of Unaudited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and nine months ended December 31, 2022, we hereby enclose a copy of Earnings Presentation for Quarter 3 / 9 Months - Financial Year 2022-2023. The said Earnings Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com